Last10K.com

Aleafia Health Inc. (1754664) SEC Filing 6-K Foreign Issuer report for the period ending Thursday, March 7, 2019

Aleafia Health Inc.

HISTORY TOOLS
CIK: 1754664

View differences made from one to another to evaluate Aleafia Health Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aleafia Health Inc..

Continue

Assess how Aleafia Health Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aleafia Health Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Aleafia Health Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
CIK: 1754664
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001062993-19-001195
Submitted to the SEC: Fri Mar 08 2019 6:04:05 AM EST
Accepted by the SEC: Fri Mar 08 2019
Period: Thursday, March 7, 2019
Industry: Medicinal Chemicals And Botanical Products

External Resources:

Bookmark the Permalink:
https://last10k.com/sec-filings/1754664/0001062993-19-001195.htm